The total number of records retrieved from this search are 4. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_2257	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	A-172	NA	NA	MTS assay	1 MOI	50% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2262	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	A-172	NA	NA	MTS assay	3 MOI	38% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2267	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	A-172	NA	NA	MTS assay	10 MOI	30% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_4329	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human glioblastoma	A-172	4000 cells per well	NA	MTT assay	10 pfu	98.7 % cell viability after 72 hours	No	No	NA	No response	NA	Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	NA	NA	26373347